期刊文献+

活性维生素D_3对2型糖尿病患者胰岛素抵抗的影响研究 被引量:10

Effect of active vitamin D_3 on insulin resistance in patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨活性维生素D3对2型糖尿病患者胰岛素抵抗的影响。方法选取2型糖尿病患者50例,患者在继续常规降糖治疗的基础上,给予活性维生素D_30.25μg口服,1次/d,治疗3个月。观察并比较患者治疗前后糖代谢指标、炎症指标、骨代谢指标的变化。结果活性维生素D_3治疗后,患者血清肌酐、空腹血糖、胰岛素抵抗指数、TNF-α、IL-6水平均低于治疗前(均P<0.05),25-羟基维生素D[25-(OH)D]水平高于治疗前(均P<0.05)。患者治疗前后甲状旁腺激素、血钙、血磷、钙磷乘积、胰岛素样生长因子-1等骨代谢指标比较差异均无统计学意义(均P>0.05)。结论 2型糖尿病患者补充活性维生素D_3治疗可以减轻胰岛素抵抗和炎症反应,改善糖代谢。活性维生素D3可能是通过抑制炎症反应起到减轻2型糖尿病患者胰岛素抵抗的作用。 Objective To investigate the effect of active vitamin D3 on insulin resistance in patients with type 2 diabetes mellitus(T2 DM). Methods Fifty patients with T2 DM were given active vitamin D3(calcitriol) 0.25μg q.d. orally for 3 months in addition to routine hypoglycemic therapy. The changes of glycometabolism, inflammation and bone metabolism were determined before and after treatment.Results After treatment with active vitamin D3, serum creatinine, fasting blood sugar, insulin resistance index, TNF-αand IL-6 were lower than those before treatment(all P<0.05). There was no significant difference in bone metabolic indexes such as parathyroid hormone, blood calcium, blood phosphorus, calcium-phosphorus product and insulin-like growth factor-1 before and after treatment(all P<0.05). Conclusion Active vitamin D3 supplementation can alleviate insulin resistance and inflammation and improve glucose metabolism in T2 DM patients, and its effect of reducing insulin resistance may be associated with inhibition of inflammation.
作者 杨士桂 林海 杨虹 YANG Shigui;LIN Hai;YANG Hong(Department of Endocrinology, Affiliated Third Hospital of Wenzhou Medical University, Wenzhou 325200, China)
出处 《浙江医学》 CAS 2019年第10期995-997,共3页 Zhejiang Medical Journal
关键词 2型糖尿病 维生素D 胰岛素抵抗指数 肿瘤坏死因子 白细胞介素-6 Type 2 diabetes mellitus Vitamin D Insulin resistance index Tumor necrosis factor IL-6
  • 相关文献

参考文献3

二级参考文献29

  • 1周翔海,纪立农.空腹血糖和糖化血红蛋白用于筛查糖尿病的研究[J].中华糖尿病杂志(1006-6187),2005,13(3):203-205. 被引量:157
  • 2孙冬玲,顾东风.代谢综合征的定义及其流行病学[J].中华预防医学杂志,2006,40(2):133-135. 被引量:89
  • 3Lee JE, Choi SY, Huh W, et al. Metabolic syndrome, C reac tive protein,and chronic kidney disease in nondiabetic,nonhy pertensive adults. Am J Hypertens,2007,20:1189 1194.
  • 4Andersen CJ, Fernandez ML. Dietary strategies to reduce metabolic syndrome. Rev Endocr Metah l)isord, 2013,14 : 24 L 254.
  • 5Ferreira I, Beijers H J, Schouten F, et al. Clustering of meta bolic syndrome traits is associated with maladaptive carotid remodeling and stiffening:a 6-year longitudinal study. Hyper tension,2012,60:542-549.
  • 6Anagnostis P,Katsiki N, Adamidou F,et al. l lbeta Hydrox ysteroid dehydrogenase type I inhibitors:novel agents for the treatment of metabolic syndrome and obesity related disor dersV Metabo[ism,2013,62:21-33.
  • 7Yang M, Liu R, Li S, et al. Zine-a2-glycoprotein is associated with insulin resistance in humans and is regulated by hyper glycemia, hyperinsulinemia, or liraglutide administration: cross sectional and interventional studies in normal subjects, insulin-resistnat subjects, and subjects with newly diagnosed diabetes. Diabetes Care, 2013,36 : 1074-1082.
  • 8Shibata R,Ouehi N, Takahashi R, et al. Omentin as a novel biomarker of metabolic risk factors. Diabetol Metab Syndr, 2012,4:37.
  • 9Zhong X, Li X, I.iu F, et al. Omentin inhibits TNFa induced expression of adhesion molecules in endothelial cells via ERK/ NFxB pathway. Biochem Biophys Res Commun, 2012,425: 401-406.
  • 10Mannucci E, Monami M,Rotella CM. How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study. Nutr Metab Cardiovasc Dis, 2007,17:719-726.

共引文献43

同被引文献103

引证文献10

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部